MGR001 / Advair Diskus Local Equivalence Study in Asthma

Condition:   Asthma
Interventions:   Drug: MGR001 (Fixed dose combination of Fluticasone propionate and salmeterol xinafoate);   Drug: Advair (Fixed dose combination of Fluticasone propionate and salmeterol xinafoate);   Drug: Placebo
Sponsors:   Mylan Inc.;   Mylan Pharma UK Ltd.
Not yet recruiting – verified September 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.